Orthopaedic Lower Limb Conditions

David Hughes
  • Duration: 1h 45m

  • Ref. 200409

1.75 Hours

Deep dive into orthopaedic presentations in the lower extremity, equipping you with assessment & management skills.

Domestic Violence 3 Hour: Focus on Child Abuse

Mary Kathleen Ebener
  • Duration: 3h

  • Ref. 200390

3.00 Hours

This course focuses on child maltreatment, abuse and neglect within the larger context of domestic or family violence. While there are several explanatory models to explain how and why one seeks to hurt another, the dynamics of domestic violence are presented using Pence and Paymer’s power and control wheel as a guiding explanat....

Implicit Bias

Mary Kathleen Ebener
  • Duration: 2h

  • Ref. 200392

2.00 Hours

This learning module offers 2.0 hours of continuing education content on implicit bias. Content addresses definitions, historical background, impact in several contexts including healthcare, and strategies to mitigate implicit bias through awareness, acknowledgement, and active resistance. There is no commercial support for t....

Module 1: Diagnosis and General Management of People with, or at Increased Risk of Diabetes Mellitus

Dr Trust Zaranyika, Dr Nickson Mukapa and Dr Moris Chiwanza
  • Duration: 2h

  • Ref. 200725

By the end of this module, participants will have a thorough understanding of the diagnostic criteria, management strategies, and educational approaches necessary for effective diabetes care and prevention.

Module 7: Diabetes in Elderly Patients

Dr Trust Zaranyika, Dr Nickson Mukapa and Dr Moris Chiwanza
  • Duration: 1h

  • Ref. 200729

By the end of this module, participants will have an understanding of managing elderly people with diabetes.

General Principles of Chemical Hazards and Public Health

Nick Brooke
  • Duration: 1h

  • Ref. 199804

LabCoP’s Waste Management ECHO session, held on 6 June 2023, focused on general principles of chemical hazards and public health. Laboratory testing and other healthcare procedures involve the use of chemicals that have the potential to cause harm. Knowledge of required precautions or mitigation measures in the event of exposure....

Exploring Advancements in the Lipoarabinomannan (LAM) Diagnostic Development Pipeline

Lesley Scott, Dr Jeremy Nel, Anura David and Morten Ruhwald
  • Duration: 1h

  • Ref. 199814

On 4 May, ASLM’s LabCoP, in collaboration with EDCTP and TB-CAPT, convened an Extended ECHO session that focused on exploring advancements in the lipoarabinomannan (LAM) diagnostic development pipeline, approaches for clinical adoption in field settings, and strategies for quality assessment. The information in this session help....

Zimbabwe’s Experience Implementing Electronic Result Reporting

Chiedza Mguni, Norah Sukutayi Vere and Mufaro Masamha
  • Duration: 1h

  • Ref. 199806

LabCoP’s June 2022 session featured the Zimbabwe experience implementing electronic result reporting, using the SMS platform, and the impact it is having on the timely utilization of laboratory results and general HIV clients management. Laboratory results are used in the diagnosis and monitoring of treatment response among indi....

Workforce Development through Fleming Fund QWArS Project

The African Society for Laboratory Medicine (ASLM)
  • Duration: 1h

  • Ref. 199807

In this AMR CoP session, we discuss laboratory workforce development challenges. In many countries in Africa, the numbers and skills of professionals capable of generating quality antimicrobial susceptibility test (AST) laboratory results, interpreting antimicrobial resistance (AMR) data or designing relevant and representative....

External Quality Assessment for SARS-CoV-2 and Other Emerging Viruses

Prof Jan Felix Drexler and Carlo Fischer
  • Duration: 1h

  • Ref. 199815

On 10 March 2022, ASLM’s LabCoP convened a session on external quality assessment (EQA) for SARS-CoV-2 and other emerging viruses. EQA is a vital tool that provides objective evidence on the credibility of reporting test results, and labs are required to use it to monitor their performance. Conditions for the implementation of E....

The Diagnostic Evidence Hub’s Role in Accelerating Uptake of Diagnostic Innovations

Mr Mashate Silver and Dr Susie Braniff
  • Duration: 1h

  • Ref. 199818

On 8 December 2021 this special ECHO session was held to focus on the role of the Diagnostic Evidence Hub in accelerating uptake of diagnostic innovations. The Diagnostic Evidence Hub, launched in 2020 by the FASTER Project and hosted on the ASLM website, provides easy access to consolidated regulatory and performance data for t....

German Epidemic Preparedness Team Laboratory Strengthening for EQA

Dr Andreas Gilsdorf and Dr Sascha Knauf
  • Duration: 1h

  • Ref. 199820

On 28 October 2021 this Extended ECHO session focused on neglected tropical disease laboratories, their potential to act as effective reference labs with effective implementation of robust quality management systems (QMS) including external quality assessment (EQA) programs. Presentations were made by Dr Andreas Gilsdorf, Head,....

HIV VL Monitoring Among Patients on ART: Eight sub-Saharan African Countries, 2013–2018

Dr Shirley Lee Lecher
  • Duration: 1h 15m

  • Ref. 199849

LabCoP’s August 2021 ECHO session focused on sharing progress in HIV viral load (VL) monitoring among patients on antiretroviral therapy (ART) from eight sub-Saharan Africa countries between 2013 and 2018. Monitoring of VL suppression at individual and population level is necessary to ensure achievement of global epidemic contro....

Innovating for Tuberculosis Diagnostics: MTB/XDR Assays and Considerations for Implementation

Dr Collins Otieno, Ms Anura David and Dr Pedro Da Silva
  • Duration: 1h 15m

  • Ref. 199851

On 15 July 2021 this Extended ECHO session was convened to discuss the WHO`s End TB Strategy that requires universal drug susceptibility testing and treatment of all tuberculosis case. Fewer than desired drug-resistant tuberculosis cases receive appropriate treatment due to either limited access to or sophisticated laboratory in....

Tuberculosis and the COVID-19 Pandemic: Tackling the Challenge

Rinuka Garde, Lucica Ditu, Prof Moses Joloba and Tamryan Green
  • Duration: 1h 15m

  • Ref. 199859

On 29 April, 2021 this COVID-19 ECHO session was convened to discuss tuberculosis (TB) and the COVID-19 pandemic. This panel discussion session was moderated by Rinuka Garde, Senior Advisor at the Clinton Health Access Initiative, and included three renowned experts in the field of TB and general lung health, including: Lucica D....

Africa CDC Trusted Travel Platform

Dr. Adam, Dr. Talkmore Maruta, and Mr Nqobile Ndlovu
  • Duration: 1h

  • Ref. 199862

On 8 April, 2021 this COVID-19 ECHO session was convened to discuss the Africa CDC Trusted Travel Platform and how to create a ‘Trusted Network’ of COVID-19 testing laboratories in Africa. To support the reopening of boarders and economies without risking disease spread, Africa CDC and partners are championing the concept of Tru....

Outcomes, Successes and Lessons

Dr Jean-Frederic Flandin, and Dr Amina Al-Mayé Bit Younouss
  • Duration: 1h

  • Ref. 199866

On 17 March, 2021 this COVID-19 ECHO session was convened to discuss outcomes, successes and lessons from implementing emergency SARS-CoV-2 external quality assessment proficiency testing in Africa. The African Joint taskforce on Coronavirus (AFTCOR) guidance objective 2 under Laboratory diagnosis is to ensure quality-assured te....

Introduction to Monitoring and Evaluation for Viral Load

Dr Getachew Kassa
  • Duration: 1h

  • Ref. 199868

On 18 February 2021, the LabCoP M&E Sub-Community of Practice held its second session that unpacked the fundamentals of monitoring and evaluation (M&E) and its importance in viral load (VL) monitoring. The use of VL data is essential for patient-level and program-level decision making. VL data is often unavailable, delayed, or u....

Infection Prevention

Dr Sarah Little
  • Duration: 1h

  • Ref. 199767

This module provides training and mentorship on infection prevention.

Maternal Resuscitation

Dr Sarah Little
  • Duration: 1h

  • Ref. 199768

This module provides training and mentorship instruction on how to perform maternal resuscitation.

Human Trafficking: Providing Meaningful Intervention

Diana Kovacic, DNP, RN; and Debra Holbrook, MSN, RN, SANE A, FNE A/P, DF-AFN, FAAN
  • Duration: 2h

  • Ref. 199633

2.00 Hours

Victims of human trafficking (HT) often encounter health care providers (HCPs) while being trafficked, yet many HCPs lack adequate training regarding the issue. This module will provide an overview of HT, including common forms. Indicators of HT and vulnerabilities associated with HT will be reviewed. Health consequences victims....

Epilepsy, Seizures and Status Epilepticus

Anthony Absalom, Dinesh Nethirasigamani and William Rutherford
  • Duration: 1h

  • Ref. 199828

This session gives an overview of the emergency and early management of seizures in adults and children, including the management of status epilepticus.

Organ Trauma: Vascular Iatrogenic Trauma and Intravascular Drug Abuse

Morgan P. McMonagle
  • Duration: 1h

  • Ref. 199831

This session describes the types of localised trauma often seen after iatrogenic instrumentation of the peripheral vessels and chronic intravenous drug abuse. This includes complicated groin with bleeding, pseudoaneurysm formation with the potential for superinfection and mycotic aneurysm formation.

Opioids in Pain Management – Advanced Knowledge

Martine Meyer
  • Duration: 1h

  • Ref. 199774

This advanced session looks at the properties of the main opioids used in the UK, when to switch opioids, particularly in renal impairment, and when to use subcutaneous opioid preparations.

Lesson 6: Follow-Up Schedule and Visit Components

Jhpiego, an affiliate of Johns Hopkins University
  • Ref. 200021

In this lesson, we will explore the different types of long-acting injectable cabotegravir (CAB-LA) visits and scheduling for routine monitoring and follow-up activities.